Rilpivirine Completed Phase 4 Trials for Healthy Volunteers Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02530060A Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male Participants
NCT01804244A Single-Dose Pharmacokinetics and Safety Study of TMC278 in Healthy Adult Japanese Participants